Last week, the Launching Ceremony of Lianhua Qingwen Capsules in Liberia was held in the Chinese Embassy to Liberia. The Chinese ambassador Ren Yisheng, Liberian Minister of Health Wilhemina Jallah, Defense Minister D. D. Ziankahn, Minister of State without Portfolio Trokon Kpui, senior Liberian and Chinese officials attended the event. Ren Yisheng said that TCM is […]
As China’s first national-level consumer expo and the largest such kind in the Asia-pacific region, the 2nd China International Consumer Products Expo (CICPE) attracted many audiences from different countries. And as the TOP 10 Chinese TCM Enterprise, Yiling Pharma (002603.SZ) presented its Lianhua health products on the expo. 30 years ago, Yiling was founded by Professor Wu Yiling (who […]
On July 6, the Summit Forum on Research and Innovation Transformation on TCM Collateral Disease was held in Yiling Pharmaceutical, Shijiazhuang City, Hebei Province, China. Academicians Zhang Boli, Wu Yiling, as well as renowned experts and scholars gathered together to have carried on in-depth exchanges on the important achievements made in the inheritance, innovation, and transformation of […]
SHIJIAZHUANG, China, May 12, 2022 — Yiling Pharmaceutical disclosed Wednesday that it had received the medicine approval document for Lianhua Qingwen Capsules from the National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria. The Product Category is Herbal and Nutraceuticals. Lianhua Qingwen is one of Yiling’s leading products. As a drug included in […]
SHIJIAZHUANG, China, April 30, 2022 — Yiling Pharmaceutical released its 2021 Annual Report Friday and disclosed the main development statistics. According to the report, its annual revenue reached USD 1.53 billion, an increase of 15.19% from last year, besides, net profit attributable to equity holders reached USD 203.75 million, achieving a 10.27% growth YoY. The […]
SHIJIAZHUANG, China, March 21, 2022 — On March 19, the Media Briefing on Prevention and Control of COVID-19 with Lianhua Qingwen Capsules, a patented Chinese medicine developed and produced by Yiling Pharmaceutical, was convened in Shijiazhuang City, Hebei Province, at which the in vitro experimental results of Lianhua Qingwen Capsules against SARS-CoV-2 Omicron variant by […]
Chinese drug producer Shijiazhuang Yiling Pharmaceutical, supplier of the famous Chinese herbal medicine, Lianhua Qingwen, has ramped up production to provide the much needed treatment to the Hong Kong Special Administrative Region (HKSAR). The measure came as an answer to the call to support the city to control the virus. In the week from February […]
“Lianhua Qingwen capsules conferred preventive effects on those exposed to COVID-19”, claimed an article titled “Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial”, published November in the journal of Evidence-based Complementary and Alternative Medicine. According to the article, this is the first clinical trial that demonstrates […]
On Sunday, 600 local families in Veal Veaeng District, Pursat Province, Cambodia, got Lianhua Qingwen Capsules, produced by Yiling Pharmaceutical, from Suy Sem, the Cambodian Minister of Mines and Energy, also president of the Cambodian central government’s assisting team to Pursat Province. Local government officials like Cheav Tay, Governor of Pursat Province were also present to help organize the distribution […]
During the efforts to prevent and control the epidemic, “3 medicines and 3 prescriptions” are selected from traditional Chinese medicine in China, including the representative medicine “Lianhua Qingwen”, produced by Yiling pharmaceutical, which has been widely used during public epidemic prevention. In addition, with the increasing popularity of the drug, scientists have carried out a series of […]